Precision BioSciences (DTIL)
(Real Time Quote from BATS)
$4.60 USD
-0.21 (-4.37%)
Updated Aug 7, 2025 01:58 PM ET
4-Sell of 5 4
D Value F Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Precision BioSciences, Inc. has a market cap of $53.33M, which represents its share price of $4.81 multiplied by its outstanding shares number of 11.09M. As a small-cap company, DTIL's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
DTIL 4.60 -0.21(-4.37%)
Will DTIL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for DTIL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DTIL
Precision BioSciences (DTIL) Reports Q2 Loss, Lags Revenue Estimates
Immunome, Inc. (IMNM) Reports Q2 Loss, Beats Revenue Estimates
DTIL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Qiagen (QGEN) Matches Q2 Earnings Estimates
Precision BioSciences (DTIL) Reports Q1 Loss, Lags Revenue Estimates
Armata Pharmaceuticals, Inc. (ARMP) Reports Q1 Loss, Lags Revenue Estimates
Other News for DTIL
Precision BioSciences GAAP EPS of -$2.13 misses by $0.56
Precision BioSciences Q2 2025 Earnings: EPS of ($2. ...
Precision BioSciences Reports Second Quarter 2025 Financial Results and Provides Business ...
Precision BioSciences Q2 2025 Earnings Preview
Precision BioSciences reports safety, efficacy data for ELIMINATE-B trial cohort